
Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
Keywords: AS; ankylosing spondylitis; ATA; anti-therapeutic antibodies; BASDAI; Bath Ankylosing Spondylitis Disease Activity Index; DAS28; Disease Activity Score 28; DMARDs; disease-modifying antirheumatic drugs; ECL; electrochemiluminescence; LoD; limit of detecti